Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
BLCM | BELLICUM PHARMACEUTICALS, INC | President and CEO, Director | $576K | Aug 15, 2022 | ||
CLVS | Clovis Oncology, Inc. | Director | Jun 10, 2021 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|